<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                   FORM 10-K/A
                                  (Amendment I)

                        FOR ANNUAL AND TRANSITION REPORTS
                     PURSUANT TO SECTION 13 OR 15 (d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

(Mark One)

            (X) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934
                   For the fiscal year ended December 31, 1997

                                       OR

            ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934
                    For the transition period from ____ to ____

                          Commission file number 1-5439

                             DEL LABORATORIES, INC.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)

         Delaware                                        13-1953103
-------------------------------                 -----------------------------
(State or other jurisdiction of                 (I.R.S. Employer I.D. Number)
 incorporation or organization)

178 EAB Plaza, Uniondale, NY                                 11556
---------------------------------------                    ----------
(Address of Principal Executive Offices)                   (Zip Code)

Registrant's telephone number, including area code: (516) 844-2020


           SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:

Title of each class              Name of each exchange on which registered
--------------------------       -----------------------------------------
Common Stock, $1 par value       American Stock Exchange

           SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:

NONE

Indicate by check mark whether the Registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of Registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [X]

The aggregate market value of the Common Stock held by non-affiliates of the
Registrant on March 27, 1998 was $155,518,165. On such date, the average bid and
asked price for the Common Stock was $33.13 per share.

The number of shares of Common Stock outstanding as of March 27, 1998 was
7,616,041 shares.

                      DOCUMENTS INCORPORATED BY REFERENCE:

<TABLE>
<CAPTION>
                                              Part of the Form 10-K into
                                              which the Document is
Document                                      Incorporated
--------                                      --------------------------
<S>                                           <C>      
Definitive Proxy Statement for 1998 Annual    Part III, Items 10, 11, 12 and 13
Meeting of Stockholders

</TABLE>

<PAGE>

Explanatory Note
----------------

THE INFORMATION CONTAINED HEREIN WITH RESPECT TO THE FIRST AND SECOND 
QUARTERS OF 1997 HAS BEEN RESTATED ON MAY 15, 1998 TO REFLECT SHIPMENTS OF 
FINISHED PRODUCTS WHICH SHOULD HAVE BEEN RECOGNIZED IN THE SECOND QUARTER OF 
1997 INSTEAD OF THE FIRST QUARTER OF 1997. THE COMPANY HAS RESTATED 
PREVIOUSLY ISSUED FINANCIAL RESULTS FOR EACH OF THE FIRST AND SECOND QUARTERS 
OF THE YEAR ENDED DECEMBER 31, 1997. THE RESTATEMENTS DID NOT IMPACT REPORTED 
RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 1997 OR THE YEAR ENDED DECEMBER 31, 
1997. THE FOLLOWING SUMMARIZES THE IMPACT OF THE RESTATEMENTS:

<TABLE>
<CAPTION>

                                                      Year Ended December 31, 1997
                                               ----------------------------------------
                                               First Quarter             Second Quarter
                                               -------------             --------------
<S>                                            <C>                       <C>    
Net Sales
         As previously reported                    $61,319                    $67,989
         As restated                                54,215                     75,093

Cost of goods sold
         As previously reported                     23,809                     26,719
         As restated                                21,386                     29,142

Net Earnings
         As previously reported                      3,295                      3,193
         As restated                                 1,061                      5,427

Earnings Per Common Share: Basic
         As previously reported                        .44                        .42
         As restated                                   .14                        .72

Earnings Per Common Share: Diluted
         As previously reported                        .41                        .39
         As restated                                   .13                        .66

</TABLE>


<PAGE>



                     DEL LABORATORIES, INC. AND SUBSIDIARIES
              Notes to Consolidated Financial Statements, Continued


(16)     Unaudited Quarterly Financial Data
         ----------------------------------

The following is a summary of quarterly operating results (in thousands of
dollars except per share amounts):

<TABLE>
<CAPTION>

                                                                          Year Ended December 31, 1997
                                                          -------------------------------------------------------
                                                           First          Second        Third            Fourth
                                                          Quarter         Quarter       Quarter          Quarter
                                                          -------         -------       -------          -------
<S>                                                       <C>             <C>           <C>              <C>    
Net sales                                                 $54,215         $75,093       $68,865          $64,837
Cost of goods sold                                         21,386          29,142        26,541           24,020
Net earnings                                                1,061           5,427         3,675            2,964
Earnings per common share
         Basic                                            $   .14         $   .72       $   .49          $   .39
                                                          -------         -------       -------          -------
                                                          -------         -------       -------          -------
         Diluted                                          $   .13         $   .66       $   .44          $   .36
                                                          -------         -------       -------          -------
                                                          -------         -------       -------          -------
</TABLE>

<TABLE>
<CAPTION>


                                                                      Year Ended December 31, 1996
                                                          ------------------------------------------------------
                                                           First          Second         Third           Fourth
                                                          Quarter         Quarter       Quarter          Quarter
                                                          -------         -------       -------          -------
<S>                                                       <C>             <C>           <C>              <C>
Net sales                                                 $56,094         $58,060       $60,354          $58,443
Cost of goods sold                                         22,815          24,216        27,612           22,877
Net earnings                                                2,388           2,197         2,575            2,118
Earnings per common share
         Basic                                            $   .32         $   .29       $   .35          $   .29
                                                          -------         -------       -------          -------
                                                          -------         -------       -------          -------
         Diluted                                          $   .29         $   .27       $   .32          $   .26
                                                          -------         -------       -------          -------
                                                          -------         -------       -------          -------

</TABLE>

Earnings per share calculations for each of the quarters are based on weighted
average number of shares outstanding in each period. Therefore, the sum of the
quarters in a year does not necessarily equal the year's earnings per share.


                                      F-24


<PAGE>